Covid-19 (Temas de Saúde Pública)
Relato | 376.000 pessoas no Reino Unido tiveram sintomas de “long Covid” por, pelo menos, 1 ano.
8 Jun, 2021 | 10:25h376,000 people in UK have had long Covid symptoms for at least a year – ONS – The Guardian
Relatório original: Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 4 June 2021 – Office for National Statistics
Estudo mostra atividade reduzida de anticorpos neutralizantes, induzida pela vacina da Pfizer–BioNTech, contra as variantes de preocupação do SARS-CoV-2 B.1.617.2 (Delta) e B.1.351 (Beta).
7 Jun, 2021 | 10:31h
Comentário no Twitter (fio – clique para saber mais)
“Immune escape” in #DeltaVariant. That’s the latest finding – that #B16172 is as bad for antibody neutralization as the Beta variant #B1351 from South Africa 🇿🇦. 1st dose alone very small effect— 2 doses needed, but weakest against Delta. Let’s walk through evidence 🧵 #COVID19 https://t.co/GurgkNVgiY pic.twitter.com/o0s9WIudCW
— Eric Feigl-Ding (@DrEricDing) June 5, 2021
6 meses de vacinas contra COVID: o que 1,7 bilhão de doses ensinaram aos cientistas.
7 Jun, 2021 | 10:30hSix months of COVID vaccines: what 1.7 billion doses have taught scientists – Nature
Ver também: Coronavirus (COVID-19) Vaccinations – Our World in Data
Comentário relacionado no Twitter
• To administer the first half a billion vaccines took 113 days
• The second half a billion 30 days
• The third half a billion 23 days
• And the fourth half a billion were administered in the last 16 daysWe keep on counting on @OurWorldInData here: https://t.co/7lOyDamxxx pic.twitter.com/Pg7OPJxliI
— Max Roser (@MaxCRoser) June 4, 2021
Aprovação da vacina CoronaVac pela OMS será crucial na contenção da pandemia.
7 Jun, 2021 | 10:29hWHO approval of Chinese CoronaVac COVID vaccine will be crucial to curbing pandemic – Nature
Relacionado: WHO validates Sinovac-CoronaVac COVID-19 vaccine for emergency use and issues interim policy recommendations E Brazilian town experiment shows mass vaccination can wipe out COVID-19.
Mais dados sobre os efeitos danosos da pandemia de COVID-19 na saúde mental de adolescentes.
7 Jun, 2021 | 10:25hComentários: A lost generation? COVID-19 and adolescent mental health – The Lancet Psychiatry E COVID-19 pandemic has had significant impact on the mental health of adolescents – Columbia University Mailman School of Public Health
Comentário no Twitter (fio – clique para saber mais)
"Evidence in support of an increase in mental health problems among adolescents during #COVID19 is accumulating, with girls and older adolescents disproportionately negatively affected."
New #Free Researchhttps://t.co/kcmPGbUrIX
— The Lancet Psychiatry (@TheLancetPsych) June 4, 2021
Investigação | Covid-19: Como a indústria do tabaco aproveitou a pandemia para promover a nicotina.
7 Jun, 2021 | 10:24hComentários: Researchers report how the tobacco and e-cigarette industry capitalized on COVID-19 to promote smoking – News Medical E Investigation discredits studies suggesting lower COVID-19 risk for smokers
Mais um estudo mostra alta frequência de uso de antibióticos em pacientes hospitalizados com Covid-19 (85,2%), apesar das baixas taxas de confirmação de infecções bacterianas secundárias.
4 Jun, 2021 | 08:27hComentários: Very high use of antibiotics in COVID-19 treatment could be reduced – University of Glasgow E More evidence of frequent antibiotic use noted in COVID patients – CIDRAP E Covid-19: Antimicrobial use was high during first wave despite bacterial co-infections being rare, study finds – The BMJ
Relacionado: Many hospitalized Covid-19 patients are given antibiotics. That’s a problem – STAT
Comentário no Twitter (fio – clique para saber mais)
Our paper on co-infections, secondary infections & antimicrobial use in patients hospitalised with #COVID19 in UK during the 1st wave is out in @LancetMicrobe!@ISARIC1 @CCPUKstudy @CVRinfo @UofGlasgow @EdinburghUni @LivUni @imperialcollege https://t.co/QYU1B2Eyup
A🧵
— Antonia Ho (@DrToniHo) June 3, 2021
Estudo randomizado: Profilaxia pós-exposição com banlanivimabe reduziu a incidência de Covid-19 entre residentes e equipe de enfermagem de casas de repouso.
4 Jun, 2021 | 08:26hEditorial: Bamlanivimab for Prevention of COVID-19
[Preprint] A “variante de preocupação” da Covid-19 B.1.617.2 (Delta) está associada a uma maior transmissibilidade em comparação com a variante B.1.1.7 (Alfa), o que levará a variante Delta a se tornar dominante no Reino Unido.
4 Jun, 2021 | 08:23hRelacionado: Covid: Indian variant ‘now dominant’ in the UK – BBC
Estados Unidos divulgam esquema de compartilhamento global de 80 milhões de doses de vacina até o fim de junho.
4 Jun, 2021 | 08:21hVer também: Statement by President Joe Biden on Global Vaccine Distribution – The White House


